Medix (331A) · InitiativeAdvanced
Overseas Expansion and Overseas Marketing Support for Existing Customers
First written in FY2026-H1. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Building an Order-Winning Base for Global Marketing ServicesA theme 7 companies write about · 0 as a headwind · 8 as a tailwind
5 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2026AdvancedAnnual report
「On 15 January 2026, the Company acquired shares in 亞星通股份有限公司. The voting rights acquired totaled 76.91%.」
For 亞星通股份有限公司, whose acquisition date had previously been undetermined, the share acquisition was completed on 15 January 2026, and the company and its 3 subsidiaries became consolidated subsidiaries. - FY2026-H1First statedAnnual report
「We are acquiring these shares to expand our business through overseas expansion and strengthen overseas marketing support for existing customers, thereby accelerating business growth. Voting rights acquired: 76.91%」
The acquisition of shares in 亞星通股份有限公司 indicates plans to expand into support for the overseas expansion and local marketing of Japanese D2C companies in Taiwan and other overseas markets. The business combination date has not been determined.